Trial Details

TERMINATED
Basic Information
Clinical ID c1297
Identifier NCT03759041
Trial Title A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Vancomycin Pre-Treatment|DRUG: Placebo for Vancomycin Pre-Treatment|DRUG: SER-287|DRUG: Placebo for SER-287
Participant Information
Sponsor Seres Therapeutics, Inc.
City Phoenix
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2018-12-19
Primary Completion Date 2021-05-28
Completion Date 2021-10-13